Thrivent Financial for Lutherans’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
14,187
-196
| -1% | -$22.3K | ﹤0.01% | 1491 |
|
|
2025
Q1 | $1.51M | Sell |
14,383
-726
| -5% | -$76.3K | ﹤0.01% | 1444 |
|
|
2024
Q4 | $1.62M | Buy |
15,109
+25
| +0.2% | +$2.68K | ﹤0.01% | 1594 |
|
|
2024
Q3 | $1.51M | Buy |
15,084
+329
| +2% | +$32.9K | ﹤0.01% | 1643 |
|
|
2024
Q2 | $1.24M | Sell |
14,755
-243
| -2% | -$20.5K | ﹤0.01% | 1721 |
|
|
2024
Q1 | $1.1M | Sell |
14,998
-386
| -3% | -$28.2K | ﹤0.01% | 1861 |
|
|
2023
Q4 | $1.1M | Sell |
15,384
-359
| -2% | -$25.6K | ﹤0.01% | 1783 |
|
|
2023
Q3 | $943K | Sell |
15,743
-774
| -5% | -$46.4K | ﹤0.01% | 1784 |
|
|
2023
Q2 | $1.19M | Sell |
16,517
-269
| -2% | -$19.4K | ﹤0.01% | 1685 |
|
|
2023
Q1 | $1.24M | Buy |
16,786
+323
| +2% | +$23.8K | ﹤0.01% | 1648 |
|
|
2022
Q4 | $1.1M | Sell |
16,463
-10,115
| -38% | -$676K | ﹤0.01% | 1668 |
|
|
2022
Q3 | $1.43M | Buy |
26,578
+23
| +0.1% | +$1.24K | ﹤0.01% | 1442 |
|
|
2022
Q2 | $1.48M | Buy |
26,555
+4,746
| +22% | +$264K | ﹤0.01% | 1435 |
|
|
2022
Q1 | $1.53M | Buy |
21,809
+8
| +0% | +$561 | ﹤0.01% | 1507 |
|
|
2021
Q4 | $2.1M | Buy |
21,801
+193
| +0.9% | +$18.6K | ﹤0.01% | 1363 |
|
|
2021
Q3 | $1.88M | Buy |
21,608
+14,521
| +205% | +$1.26M | ﹤0.01% | 1390 |
|
|
2021
Q2 | $580K | Buy |
7,087
+8
| +0.1% | +$655 | ﹤0.01% | 2131 |
|
|
2021
Q1 | $673K | Sell |
7,079
-87,948
| -93% | -$8.36M | ﹤0.01% | 2098 |
|
|
2020
Q4 | $5.9M | Buy |
95,027
+703
| +0.7% | +$43.6K | 0.01% | 804 |
|
|
2020
Q3 | $5.61M | Sell |
94,324
-2,648
| -3% | -$157K | 0.02% | 760 |
|
|
2020
Q2 | $6.77M | Sell |
96,972
-78,744
| -45% | -$5.49M | 0.02% | 645 |
|
|
2020
Q1 | $7.97M | Sell |
175,716
-671,425
| -79% | -$30.5M | 0.03% | 559 |
|
|
2019
Q4 | $55.1M | Buy |
847,141
+130,018
| +18% | +$8.46M | 0.16% | 175 |
|
|
2019
Q3 | $44.5M | Buy |
717,123
+22,008
| +3% | +$1.37M | 0.14% | 181 |
|
|
2019
Q2 | $49.5M | Buy |
695,115
+11,081
| +2% | +$789K | 0.15% | 169 |
|
|
2019
Q1 | $53.6M | Buy |
684,034
+236,502
| +53% | +$18.5M | 0.17% | 163 |
|
|
2018
Q4 | $37.9M | Buy |
447,532
+424,470
| +1,841% | +$35.9M | 0.14% | 181 |
|
|
2018
Q3 | $3.95M | Sell |
23,062
-383
| -2% | -$65.6K | 0.01% | 706 |
|
|
2018
Q2 | $3.03M | Buy |
23,445
+662
| +3% | +$85.6K | 0.01% | 762 |
|
|
2018
Q1 | $2.35M | Buy |
22,783
+1,787
| +9% | +$184K | 0.01% | 842 |
|
|
2017
Q4 | $1.79M | Buy |
20,996
+413
| +2% | +$35.3K | 0.01% | 961 |
|
|
2017
Q3 | $1.75M | Buy |
20,583
+2,213
| +12% | +$188K | 0.01% | 911 |
|
|
2017
Q2 | $1.39M | Buy |
18,370
+1,266
| +7% | +$95.9K | 0.01% | 971 |
|
|
2017
Q1 | $1.13M | Buy |
17,104
+705
| +4% | +$46.5K | ﹤0.01% | 1098 |
|
|
2016
Q4 | $1.04M | Buy |
16,399
+866
| +6% | +$54.9K | ﹤0.01% | 1128 |
|
|
2016
Q3 | $989K | Buy |
15,533
+769
| +5% | +$49K | ﹤0.01% | 1134 |
|
|
2016
Q2 | $1.1M | Buy |
14,764
+1,860
| +14% | +$138K | 0.01% | 1068 |
|
|
2016
Q1 | $862K | Buy |
12,904
+465
| +4% | +$31.1K | ﹤0.01% | 1131 |
|
|
2015
Q4 | $841K | Buy |
12,439
+256
| +2% | +$17.3K | ﹤0.01% | 1124 |
|
|
2015
Q3 | $651K | Buy |
12,183
+1,042
| +9% | +$55.7K | ﹤0.01% | 1100 |
|
|
2015
Q2 | $701K | Buy |
11,141
+481
| +5% | +$30.3K | ﹤0.01% | 950 |
|
|
2015
Q1 | $513K | Hold |
10,660
| – | – | ﹤0.01% | 1100 |
|
|
2014
Q4 | $354K | Sell |
10,660
-401
| -4% | -$13.3K | ﹤0.01% | 1297 |
|
|
2014
Q3 | $324K | Sell |
11,061
-1,122
| -9% | -$32.9K | ﹤0.01% | 1329 |
|
|
2014
Q2 | $473K | Buy |
12,183
+160
| +1% | +$6.21K | ﹤0.01% | 1151 |
|
|
2014
Q1 | $505K | Buy |
12,023
+161
| +1% | +$6.76K | ﹤0.01% | 953 |
|
|
2013
Q4 | $389K | Buy |
+11,862
| New | +$389K | ﹤0.01% | 1109 |
|